Applying Telemedicine to Multidisciplinary Pediatric Inflammatory Bowel Disease Care

Hilary K Michel1,2, Ross M Maltz1,2,3, Brendan Boyle1,2

  • 1Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH 43205, USA.

Insights

This study details transitioning multidisciplinary pediatric inflammatory bowel disease (IBD) care to telemedicine. It highlights leveraging technology and quality improvement methods to maintain comprehensive, whole-person care during the pandemic.

Area of Science:

  • Pediatric Gastroenterology
  • Health Services Research
  • Telemedicine

Background:

  • Multidisciplinary care is crucial for comprehensive, whole-person care in pediatric and adolescent inflammatory bowel disease (IBD).
  • Traditionally, IBD care relied on in-person visits, posing challenges during the COVID-19 pandemic.
  • The pandemic necessitated rapid adoption of telemedicine to ensure continuity of care.

Purpose of the Study:

  • To describe the process of converting multidisciplinary pediatric and adolescent IBD visits to a telemedicine model.
  • To highlight the use of technology, multidisciplinary teams, and quality improvement (QI) methods in this transition.
  • To contextualize this experience within the existing literature on telemedicine in IBD care, particularly for pediatric populations.

Main Methods:

  • Implementation of a telemedicine model for multidisciplinary pediatric and adolescent IBD care.
  • Leveraging existing technology infrastructure and multidisciplinary team collaboration.
  • Application of quality improvement (QI) methodologies to optimize the telemedicine delivery model.

Main Results:

  • Successful conversion of in-person multidisciplinary IBD visits to a functional telemedicine platform.
  • Demonstrated feasibility of maintaining comprehensive, whole-person care through virtual means.
  • Experience provides a framework for other centers adapting to telemedicine in pediatric IBD.

Conclusions:

  • Telemedicine is a viable and effective modality for delivering multidisciplinary care to pediatric and adolescent IBD patients.
  • The integration of technology, multidisciplinary teams, and QI is key to successful telemedicine implementation.
  • This approach ensures continuity of care and supports the comprehensive needs of young IBD patients.

Related Concept Videos

Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
261
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
476
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
281
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
541
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
302
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
268